Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer

Cuproptosis is a novel copper ion-dependent cell death type being regulated in cells, and this is quite different from the common cell death patterns such as apoptosis, pyroptosis, necroptosis, and ferroptosis. Interestingly, like with death patterns, cuproptosis-related genes have recently been rep...

Full description

Bibliographic Details
Main Authors: Qiang Song, Rui Zhou, Fangpeng Shu, Wen Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.958368/full
_version_ 1811313839385346048
author Qiang Song
Qiang Song
Rui Zhou
Fangpeng Shu
Wen Fu
author_facet Qiang Song
Qiang Song
Rui Zhou
Fangpeng Shu
Wen Fu
author_sort Qiang Song
collection DOAJ
description Cuproptosis is a novel copper ion-dependent cell death type being regulated in cells, and this is quite different from the common cell death patterns such as apoptosis, pyroptosis, necroptosis, and ferroptosis. Interestingly, like with death patterns, cuproptosis-related genes have recently been reported to regulate the occurrence and progression of various tumors. However, in bladder cancer, the link between cuproptosis and clinical outcome, tumor microenvironment (TME) modification, and immunotherapy is unknown. To determine the role of cuprotosis in the tumor microenvironment, we systematically examined the characteristic patterns of 10 cuproptosis-related genes in bladder cancer (BLCA). By analyzing principal component data, we established a cuproptosis score to determine the degree of cuproptosis among patients. Finally, we evaluated the potential of these values in predicting BLCA prognosis and treatment responses. A comprehensive study of the mutations of cuproptosis-related genes in BLCA specimens was conducted at the genetic level, and their expression and survival patterns were evaluated using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Two cuproptosis patterns were constructed based on the transcription level of 10 cuproptosis-related genes, featuring differences in the prognosis and the infiltrating landscape of immune cells (especially T and dendritic cells) with interactions between cuproptosis and the TME. Our study further demonstrated that cuproptosis score may predict prognosis, immunophenotype sensitivity to chemotherapy, and immunotherapy response among bladder cancer patients. The development and progression of bladder cancer are likely to be influenced by cuproptosis, which may involve a diverse and complex TME. The cuproptosis pattern evaluated in our study may enhance understanding of immune infiltrations and guide more potent immunotherapy interventions.
first_indexed 2024-04-13T11:00:44Z
format Article
id doaj.art-299607fa373a45e3baef7785a30ac506
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T11:00:44Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-299607fa373a45e3baef7785a30ac5062022-12-22T02:49:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-08-011310.3389/fimmu.2022.958368958368Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancerQiang Song0Qiang Song1Rui Zhou2Fangpeng Shu3Wen Fu4Department of Urology, Guangzhou Women and Children’s Medical Center, National Children’s Medical Center for South Central Region, Guangzhou Medical University, Guangzhou, ChinaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Urology, Guangzhou Women and Children’s Medical Center, National Children’s Medical Center for South Central Region, Guangzhou Medical University, Guangzhou, ChinaDepartment of Urology, Guangzhou Women and Children’s Medical Center, National Children’s Medical Center for South Central Region, Guangzhou Medical University, Guangzhou, ChinaDepartment of Urology, Guangzhou Women and Children’s Medical Center, National Children’s Medical Center for South Central Region, Guangzhou Medical University, Guangzhou, ChinaCuproptosis is a novel copper ion-dependent cell death type being regulated in cells, and this is quite different from the common cell death patterns such as apoptosis, pyroptosis, necroptosis, and ferroptosis. Interestingly, like with death patterns, cuproptosis-related genes have recently been reported to regulate the occurrence and progression of various tumors. However, in bladder cancer, the link between cuproptosis and clinical outcome, tumor microenvironment (TME) modification, and immunotherapy is unknown. To determine the role of cuprotosis in the tumor microenvironment, we systematically examined the characteristic patterns of 10 cuproptosis-related genes in bladder cancer (BLCA). By analyzing principal component data, we established a cuproptosis score to determine the degree of cuproptosis among patients. Finally, we evaluated the potential of these values in predicting BLCA prognosis and treatment responses. A comprehensive study of the mutations of cuproptosis-related genes in BLCA specimens was conducted at the genetic level, and their expression and survival patterns were evaluated using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Two cuproptosis patterns were constructed based on the transcription level of 10 cuproptosis-related genes, featuring differences in the prognosis and the infiltrating landscape of immune cells (especially T and dendritic cells) with interactions between cuproptosis and the TME. Our study further demonstrated that cuproptosis score may predict prognosis, immunophenotype sensitivity to chemotherapy, and immunotherapy response among bladder cancer patients. The development and progression of bladder cancer are likely to be influenced by cuproptosis, which may involve a diverse and complex TME. The cuproptosis pattern evaluated in our study may enhance understanding of immune infiltrations and guide more potent immunotherapy interventions.https://www.frontiersin.org/articles/10.3389/fimmu.2022.958368/fullbladder cancercuproptosisprognosistumor microenvironmentimmunotherapy
spellingShingle Qiang Song
Qiang Song
Rui Zhou
Fangpeng Shu
Wen Fu
Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
Frontiers in Immunology
bladder cancer
cuproptosis
prognosis
tumor microenvironment
immunotherapy
title Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
title_full Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
title_fullStr Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
title_full_unstemmed Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
title_short Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
title_sort cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
topic bladder cancer
cuproptosis
prognosis
tumor microenvironment
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.958368/full
work_keys_str_mv AT qiangsong cuproptosisscoringsystemtopredicttheclinicaloutcomeandimmuneresponseinbladdercancer
AT qiangsong cuproptosisscoringsystemtopredicttheclinicaloutcomeandimmuneresponseinbladdercancer
AT ruizhou cuproptosisscoringsystemtopredicttheclinicaloutcomeandimmuneresponseinbladdercancer
AT fangpengshu cuproptosisscoringsystemtopredicttheclinicaloutcomeandimmuneresponseinbladdercancer
AT wenfu cuproptosisscoringsystemtopredicttheclinicaloutcomeandimmuneresponseinbladdercancer